How many institutions own VRPX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VRPX shares is 1, representing 0% of the company's common stock.

Who are the major shareholders selling Virpax Pharmaceuticals, Inc. stock?

GEODE CAPITAL MANAGEMENT, LLC, in the last quarter, reduced its stake in VRPX by -100% restricting it's holding to 0 shares of worth nearly -. BLACKROCK INC. also lessened -100% of the VRPX shares from its portfolio, reducing its holding to 0 shares of worth -. UBS GROUP AG also shunned VRPX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying VRPX stock?

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in VRPX by 1.76% in the last quarter. The institutional holder raised its holding to 66.29 thousand shares having worth more than $21.22K. SHEETS SMITH WEALTH MANAGEMENT also added 100% more shares of VRPX to its portfolio, raising its holding to 50 thousand shares of worth $16.01K. TWO SIGMA SECURITIES, LLC also increased its VRPX shares holding by 100% which brought its holding to 11.7 thousand shares worth $3.74K.

VRPX's major insiders: who are they?

The insider with the most stakes in VRPX is Mack Anthony P. , Chief Executive Officer at the company. Additionally, VRPX stock is highly held by Sendrow Jerrold and Floyd Eric among others.

Did an insider recently sell VRPX stock?

Company executives, directors, and other insiders own 0% percent of Virpax Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which VRPX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased VRPX stock?

There have been 0 transaction(s) during the past 6-months in which Virpax Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

How much of VRPX does insiders own?

Around 0 Virpax Pharmaceuticals, Inc. shares are held by insiders, which represents about 0% of VRPX stock.

Who is the insider with the largest stake?

VRPX Chief Executive Officer, Mack Anthony P. holds the largest portfolio of the company's shares. VRPX shares owned by Mack total nearly 252.56 thousand.

Which institution holds the most shares in VRPX?

PARALLEL ADVISORS, LLC is the largest institutional owner in VRPX which holds 1 shares worth $1.00 or 0% of the total VRPX shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 0 shares representing 0% of the VRPX ownership. BLACKROCK INC. is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Virpax Pharmaceuticals, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VRPX is concerned, it is a stock which is not optionable.

Is there a short position on VRPX's shares?

Number of VRPX shares short is 23.08K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding VRPX shares are there?

As of today, 1.24M shares of VRPX are outstanding.

Is there many float in VRPX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VRPX has 1.05M shares in float.

VRPX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VRPX is 0.04.

Virpax Pharmaceuticals (VRPX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.81

Short Percent Of Float1.81

Shares Outstanding1.24M

Shares Float1.05M

Shares Short23.08K

Short Ratio0.04

1.81%

Short % of Float

1.81%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0% Percentage of Shares held by All Insiders

0% Percentage of Shares held by All Institutions

0% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0% of VRPX shares are held by financial institutions. PARALLEL ADVISORS, LLC is the top corporate investor, holding 1 shares valued at $1.00. A 0% stake in Virpax Pharmaceuticals, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2024	PARALLEL ADVISORS, LLC	0%	1	1	0	0
Mar 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-63.93K	-100.00%
Mar 31, 2024	BLACKROCK INC.	0%	0	-	-464	-100.00%
Mar 31, 2024	UBS GROUP AG	0%	0	-	-6.62K	-100.00%
Mar 31, 2024	PNC FINANCIAL SERVICES GROUP, INC.	0%	0	-	-100.88K	-100.00%
Mar 31, 2024	MORGAN STANLEY	0%	0	-	-150	-100.00%
Mar 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-30.5K	-100.00%
Mar 31, 2024	SHEETS SMITH WEALTH MANAGEMENT	0%	0	-	-50K	-100.00%
Mar 31, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-17.73K	-100.00%
Mar 31, 2024	PARALLEL ADVISORS, LLC	0%	1	4	-13	-92.86%
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	0	-	-67	-100.00%
Mar 31, 2024	NORTHERN TRUST CORP	0%	0	-	-15.22K	-100.00%
Mar 31, 2024	VANGUARD GROUP INC	0%	0	-	-66.29K	-100.00%
Mar 31, 2024	TWO SIGMA SECURITIES, LLC	0%	0	-	-11.7K	-100.00%
Mar 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-6.32K	-100.00%
Mar 31, 2024	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-2.4K	-100.00%
Mar 31, 2024	SIGNATURE RESOURCES CAPITAL MANAGEMENT, LLC	0%	0	-	-500	-100.00%
Mar 31, 2024	JPMORGAN CHASE & CO	0%	0	-	-4.36K	-100.00%
Dec 31, 2023	VANGUARD GROUP INC	0.57%	66.29K	21.22K	1.15K	+1.76%
Dec 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.55%	63.93K	20.16K	0	0
Dec 31, 2023	SHEETS SMITH WEALTH MANAGEMENT	0.43%	50K	16.01K	50K	+100.00%
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.26%	30.5K	10K	-40.6K	-57.10%
Dec 31, 2023	NORTHERN TRUST CORP	0.13%	15.22K	4.87K	0	0
Dec 31, 2023	TWO SIGMA SECURITIES, LLC	0.1%	11.7K	3.74K	11.7K	+100.00%
Dec 31, 2023	UBS GROUP AG	0.06%	6.62K	2.12K	6.5K	+5,506.78%
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	6.32K	2.02K	98	+1.58%
Dec 31, 2023	JPMORGAN CHASE & CO	0.04%	4.36K	1.37K	4.36K	+100.00%
Dec 31, 2023	ADVISOR GROUP HOLDINGS, INC.	0.02%	2.4K	768	1.8K	+300.00%
Dec 31, 2023		0%	500	160	500	+100.00%
Dec 31, 2023	BLACKROCK INC.	0%	464	149	0	0
Dec 31, 2023	MORGAN STANLEY	0%	150	48	0	0
Dec 31, 2023	WELLS FARGO & COMPANY/MN	0%	67	21	4	+6.35%
Dec 31, 2023	PARALLEL ADVISORS, LLC	0%	14	5	14	+100.00%
Dec 31, 2023	SABBY MANAGEMENT, LLC	0%	0	-	-292.79K	-100.00%
Dec 31, 2023	PNC FINANCIAL SERVICES GROUP, INC.	0.86%	100.88K	32.28K	0	0

Insiders

Among the VRPX insiders holding of 0% of the stake in company, MACK ANTHONY P., Chief Executive Officer, holds the largest shares of 252.56K. SENDROW JERROLD, , is the second largest VRPX insider with ownership of 9.01K shares. FLOYD ERIC, , stands third with possession of 8.02K shares of that stake.

Insiders	Designation	Shares Held
MACK ANTHONY P.	Chief Executive Officer	252.56K
SENDROW JERROLD		9.01K
FLOYD ERIC		8.02K
JACOB GARY S	director	3.5K
JAMBULINGAM THANI	director	100

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
May 24, 2022	SENDROW JERROLD	PURCHASE	1.29	4.5K	5.81K	9.01K
May 18, 2022	MACK ANTHONY P.	PURCHASE	1.34	75.75K	101.51K	252.56K
May 18, 2022	FLOYD ERIC	PURCHASE	1.36	4.48K	6.11K	8.02K
Nov 22, 2021	SENDROW JERROLD	PURCHASE	3.92	3.9K	15.31K	4.51K
Nov 18, 2021	MACK ANTHONY P.	PURCHASE	3.99	25.13K	100.25K	176.81K
Feb 17, 2021	JAMBULINGAM THANI	PURCHASE	7.16	100	716	100
Feb 17, 2021	JACOB GARY S	PURCHASE	6.79	3.5K	23.76K	3.5K

VRPX Stock Ownership Breakdown